Physician profile
Lindsey M Fields
NPI 1255826541
$966.04
in general payments reported to CMS, 2019-2025
11 companies · $20.26 in 2025
The $20.26 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $69.43 · 2021: $87.22 · 2022: $232 · 2023: $279 · 2024: $155 · 2025: $20.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $454.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $264.42 | 2022-2024 | Tyrvaya |
| Abbvie INC. | $207.06 | 2022-2024 | |
| Sun Pharmaceutical Industries INC. | $124.06 | 2019-2023 | Cequa |
| Allergan, INC. | $110.91 | 2020-2022 | |
| Alcon Vision LLC | $77.33 | 2019-2023 | Total30 |
| Coopervision INC. | $45.50 | 2019-2023 | Myday Contact Lens |
| Bausch & Lomb Americas INC. | $38.11 | 2023-2025 | Vyzulta, Infuse |
| Astellas Pharma US INC | $26.94 | 2024 | Izervay |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $25.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $23.59 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $23.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.